- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VALERITAS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 372,40 | +0,59 % | UnitedHealth hebt Prognose an - Erholung bestätigt | UnitedHealth überraschte die Börse am Donnerstag mit einem starken Abschluss. Die Zahlen für das 2. Quartal und der neue Jahresausblick lagen über den Schätzungen und auch den eingepreisten Erwartungen.... ► Artikel lesen | |
| THERMO FISHER | 466,90 | -1,04 % | Thermo Fisher Scientific declares $0.47 dividend | ||
| TELADOC HEALTH | 8,058 | -2,61 % | Biotech Stocks At 52-Week Highs - CPIX, MRVI, ANGO, ACHC, TDOC | BENTONVILLE (dpa-AFX) - The following biotech stocks reached a 52-week high on July 15, 2026, driven by catalysts such as recent business developments or positive quarterly reports.Cumberland... ► Artikel lesen | |
| RESMED | 175,20 | -1,13 % | ResMed downgraded at RBC Capital Markets on FY27 challenges | ||
| HENRY SCHEIN | 76,50 | -1,29 % | What to Expect From Henry Schein's Next Quarterly Earnings Report | ||
| ZIMMER BIOMET | 81,30 | -0,78 % | Zimmer Biomet names new president of Asia Pacific | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn Wound Irrigation Solution | BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k)... ► Artikel lesen | |
| PETMED EXPRESS | 1,670 | -4,24 % | PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited | DELRAY BEACH, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds" or the "Company") (Nasdaq: PETS) today confirmed that its Board of Directors (the "Board") has received an unsolicited... ► Artikel lesen | |
| TANDEM DIABETES | 14,500 | +1,40 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| QUIDELORTHO | 15,070 | -5,07 % | QuidelOrtho Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| QUEST DIAGNOSTICS | 182,60 | -0,27 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| VERU | 2,380 | 0,00 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| SENSEONICS | 4,420 | -1,34 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,966 | 0,00 % | Tempest Therapeutics: Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026 | Advancing a pipeline of in vivo CAR-T product candidates for oncology and immunology applications differentiated by CD7-targeted mRNA/LNP delivery approachLead candidate TPST-4003 combines proprietary... ► Artikel lesen |
Das Unternehmen VALERITAS HOLDINGS INC kann der Branche Gesundheitswesen zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VALERITAS HOLDINGS INC finden Sie auf Wallstreet Online.